Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Peripheral Arterial Disease

tetradecanoylphorbol acetate has been researched along with Peripheral Arterial Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beloqui, O; Benito-Martin, A; Blanco-Colio, LM; Burillo, E; Egido, J; Fernandez-Garcia, CE; Lindholt, JS; Llamas-Granda, P; Madrigal-Matute, J; Martin-Ventura, JL; Ortiz, A; Zalba, G1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Peripheral Arterial Disease

ArticleYear
Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis.
    Journal of the American Heart Association, 2014, Aug-05, Volume: 3, Issue:4

    Topics: Aged; Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Cell Line; Female; Follow-Up Studies; Galectin 3; Humans; In Vitro Techniques; Inflammation; Macrophages; Male; Middle Aged; Monocytes; NADPH Oxidases; Oxidative Stress; Peripheral Arterial Disease; Prognosis; Tetradecanoylphorbol Acetate

2014